Safety Of DAPAGLIFLOZIN (FORXIGA) in Patient With Type 2 Diabetes Mellitus (T2dm) In Vietnam From A Post-Marketing Surveillance Program

Clinical trial NCT07210307 · COMPLETED

Trial details

NCT number: NCT07210307
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Safety Outcomes

Start date: 2017-10-31
Primary completion: 2020-03-17
Enrollment: 1001

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.